STEMLINE THERAPEUTICS INC Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in STEMLINE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in STEMLINE THERAPEUTICS INC for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 6.43 | 9,147 | 58,815 | 333,591 | 342.7 K to 333.6 K (-2.67 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.42 | 24,642 | 158,202 | 2,915,405 | 2.9 M to 2.9 M (-0.84 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 6.42 | 11,547 | 74,132 | 797,955 | 809.5 K to 798 K (-1.43 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 6.43 | 9,147 | 58,815 | 333,591 | 342.7 K to 333.6 K (-2.67 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.42 | 24,642 | 158,202 | 2,915,405 | 2.9 M to 2.9 M (-0.84 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 6.42 | 11,547 | 74,132 | 797,955 | 809.5 K to 798 K (-1.43 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 208,417 | 0 | 809,502 | 601.1 K to 809.5 K (+34.67 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 208,417 | 0 | 809,502 | 601.1 K to 809.5 K (+34.67 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Grant | A | 0.00 | 105,939 | 0 | 199,196 | 93.3 K to 199.2 K (+113.60 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Grant | A | 0.00 | 105,939 | 0 | 199,196 | 93.3 K to 199.2 K (+113.60 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 6.72 | 5,064 | 34,030 | 93,257 | 98.3 K to 93.3 K (-5.15 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 6.72 | 5,064 | 34,030 | 93,257 | 98.3 K to 93.3 K (-5.15 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 107,317 | 0 | 342,738 | 235.4 K to 342.7 K (+45.59 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 107,317 | 0 | 342,738 | 235.4 K to 342.7 K (+45.59 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 425,274 | 0 | 2,940,047 | 2.5 M to 2.9 M (+16.91 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 425,274 | 0 | 2,940,047 | 2.5 M to 2.9 M (+16.91 %) |